{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:09:01Z","timestamp":1771841341149,"version":"3.50.1"},"reference-count":75,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T00:00:00Z","timestamp":1771718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background\/Objectives: Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder classically associated with emphysema and COPD. However, emerging evidence indicates that its clinical spectrum extends to airway-predominant diseases such as bronchiectasis and asthma, where protease\u2013antiprotease imbalance and neutrophilic inflammation may drive tissue injury. This narrative review aims to synthesize current evidence on the relationship between AATD and airway diseases beyond emphysema, focusing on epidemiological patterns, underlying mechanisms, diagnostic strategies, and therapeutic implications. Methods: A narrative synthesis of the literature was performed, integrating data from registries, with observational and translational studies addressing the prevalence, pathobiology, and therapeutic implications of AATD in bronchiectasis, asthma, and severe asthma. Epidemiologic and mechanistic insights were analyzed to identify overlapping pathways and evidence gaps. Results: Evidence supports a non-negligible prevalence of bronchiectasis and asthma among AATD individuals, particularly in severe or heterozygous genotypes. Neutrophil elastase overactivity, impaired mucociliary clearance, and chronic neutrophilic inflammation emerge as shared mechanisms promoting bronchial remodeling and airflow limitation. In asthma, AATD appears linked to T2-low, steroid-resistant phenotypes and persistent obstruction, whereas in severe asthma cohorts, up to 20% may carry non-PiMM SERPINA 1 variants. No randomized trials have evaluated augmentation therapy and standardized screening algorithms are lacking. Conclusions: AATD represents a systemic disorder with clinically relevant airway manifestations beyond COPD and emphysema. Targeted testing should be considered in patients with idiopathic bronchiectasis or severe asthma. Future genotype-stratified, prospective studies are required to clarify causality, define biomarkers of disease activity, and evaluate the potential role of anti-protease-based therapeutic strategies.<\/jats:p>","DOI":"10.3390\/medsci14010106","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T08:58:21Z","timestamp":1771837101000},"page":"106","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alpha-1 Antitrypsin Deficiency Beyond COPD and Emphysema: A Narrative Review"],"prefix":"10.3390","volume":"14","author":[{"given":"Lucia","family":"Pastoressa","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8768-065X","authenticated-orcid":false,"given":"Vanessa","family":"Pivetti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialuisa","family":"Valente","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Begh\u00e8","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy"},{"name":"Respiratory Diseases Unit, University Hospital of Modena\u2014Policlinico, 41124 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1515-5094","authenticated-orcid":false,"given":"Enrico","family":"Clini","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy"},{"name":"Respiratory Diseases Unit, University Hospital of Modena\u2014Policlinico, 41124 Modena, Italy"},{"name":"Center for Rare Lung Diseases, University Hospital of Modena\u2014Policlinico, 41124 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Tonelli","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy"},{"name":"Respiratory Diseases Unit, University Hospital of Modena\u2014Policlinico, 41124 Modena, Italy"},{"name":"Center for Rare Lung Diseases, University Hospital of Modena\u2014Policlinico, 41124 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4612-1580","authenticated-orcid":false,"given":"Stefania","family":"Cerri","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy"},{"name":"Respiratory Diseases Unit, University Hospital of Modena\u2014Policlinico, 41124 Modena, Italy"},{"name":"Center for Rare Lung Diseases, University Hospital of Modena\u2014Policlinico, 41124 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Mazzuca, C., Vitiello, L., Travaglini, S., Maurizi, F., Finamore, P., Santangelo, S., Rigon, A., Vadacca, M., Angeletti, S., and Scarlata, S. (2024). Immunological and Homeostatic Pathways of Alpha -1 Antitrypsin: A New Therapeutic Potential. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1443297"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.15537\/smj.2022.43.12.20210398","article-title":"Role and Mechanism of Alpa1-Antitrypsin in Polycystic Ovary Syndrome","volume":"43","author":"Pan","year":"2022","journal-title":"Saudi Med. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.rmed.2011.02.002","article-title":"The Discovery of A1-Antitrypsin and Its Role in Health and Disease","volume":"105","author":"Janciauskiene","year":"2011","journal-title":"Respir. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.1513\/AnnalsATS.201509-634KV","article-title":"The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency","volume":"13","author":"McCarthy","year":"2016","journal-title":"Annals ATS"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1164\/rccm.201108-1428CI","article-title":"A Review of \u03b11 -Antitrypsin Deficiency","volume":"185","author":"Stoller","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha1 -Antitrypsin Deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2040622321995691","DOI":"10.1177\/2040622321995691","article-title":"The Spectrum of Clinical Sequelae Associated with Alpha-1 Antitrypsin Deficiency","volume":"12","author":"Tejwani","year":"2021","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"104174","DOI":"10.1016\/j.lpm.2023.104174","article-title":"Bronchiectasis","volume":"52","author":"Barbosa","year":"2023","journal-title":"La Presse M\u00e9dicale"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-0041-1730891","article-title":"Pathophysiology of Bronchiectasis","volume":"42","author":"Keir","year":"2021","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"240055","DOI":"10.1183\/16000617.0055-2024","article-title":"Pathophysiology and Genomics of Bronchiectasis","volume":"33","author":"Perea","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"240179","DOI":"10.1183\/16000617.0179-2024","article-title":"Neutrophilic Inflammation in Bronchiectasis","volume":"34","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Oriano, M., Amati, F., Gramegna, A., De Soyza, A., Mantero, M., Sibila, O., Chotirmall, S.H., Voza, A., Marchisio, P., and Blasi, F. (2021). Protease\u2013Antiprotease Imbalance in Bronchiectasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115996"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","article-title":"Non\u2013Cystic Fibrosis Bronchiectasis","volume":"188","author":"McShane","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.arbres.2022.09.004","article-title":"Pathophysiology of Chronic Bronchial Infection in Bronchiectasis","volume":"59","author":"Solarat","year":"2023","journal-title":"Arch. Bronconeumol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13023-023-02830-2","article-title":"The Prevalence of Bronchiectasis in Patients with Alpha-1 Antitrypsin Deficiency: Initial Report of EARCO","volume":"18","author":"Stockley","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1164\/rccm.200703-489OC","article-title":"Prevalence and Impact of Bronchiectasis in \u03b11 -Antitrypsin Deficiency","volume":"176","author":"Parr","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.15326\/jcopdf.2024.0526","article-title":"Bronchiectasis Occurs Independently of Chronic Obstructive Pulmonary Disease in Alpha-1 Antitrypsin Deficiency","volume":"11","author":"Ellis","year":"2024","journal-title":"J. COPD Found."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sanduzzi, A., Ciasullo, E., Capitelli, L., Sanduzzi Zamparelli, S., and Bocchino, M. (2020). Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17072294"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/thoraxjnl-2019-214195","article-title":"Utility of Routine Screening for Alpha-1 Antitrypsin Deficiency in Patients with Bronchiectasis","volume":"75","author":"Carreto","year":"2020","journal-title":"Thorax"},{"key":"ref_20","first-page":"3330","article-title":"Alpha-1 Antitrypsin Deficiency in Patients with Bronchiectasis: Data from the European Bronchiectasis Registry EMBARC","volume":"56","author":"Loebinger","year":"2020","journal-title":"Eur. Respir. Soc."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Voynow, J.A., and Shinbashi, M. (2021). Neutrophil Elastase and Chronic Lung Disease. Biomolecules, 11.","DOI":"10.3390\/biom11081065"},{"key":"ref_22","first-page":"S123","article-title":"Neutrophil Fates in Bronchiectasis and Alpha-1 Antitrypsin Deficiency","volume":"13","author":"Russell","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12931-023-02343-3","article-title":"Lung Inflammation in Alpha-1-Antitrypsin Deficient Individuals with Normal Lung Function","volume":"24","author":"Kokturk","year":"2023","journal-title":"Respir. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.15326\/jcopdf.7.3.2019.0164","article-title":"Neutrophil Modulation in Alpha-1 Antitrypsin Deficiency","volume":"7","author":"Sapey","year":"2020","journal-title":"J. COPD Found."},{"key":"ref_25","first-page":"A34","article-title":"S40\u2005Radiological Bronchiectasis vs Outcomes in Alpha-1 Antitrypsin Deficiency","volume":"79","author":"Ellis","year":"2024","journal-title":"Thorax"},{"key":"ref_26","first-page":"PA4359","article-title":"Bronchiectasis in Alpha1-Antitrypsin Deficiency","volume":"54","author":"Farinha","year":"2019","journal-title":"Eur. Respir. Soc."},{"key":"ref_27","first-page":"101740","article-title":"Augmentation Therapy with Human Alpha-1-Proteinase Inhibitor Reduces Exacerbations in Patient with Bronchiectasis and Alpha-1-Antitrypsin Deficiency","volume":"39","author":"Buck","year":"2022","journal-title":"Respir. Med. Case Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/JIR.S156405","article-title":"The Impact of Alpha-1 Antitrypsin Augmentation Therapy on Neutrophil-Driven Respiratory Disease in Deficient Individuals","volume":"11","author":"Dunlea","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"230170","DOI":"10.1183\/16000617.0170-2023","article-title":"Nine Controversial Questions about Augmentation Therapy for Alpha-1 Antitrypsin Deficiency: A Viewpoint","volume":"32","author":"Miravitlles","year":"2023","journal-title":"Eur. Respir. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society Guidelines for the Management of Adult Bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e000348","DOI":"10.1136\/bmjresp-2018-000348","article-title":"British Thoracic Society Guideline for Bronchiectasis in Adults","volume":"5","author":"Hill","year":"2018","journal-title":"BMJ Open Resp. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"668","DOI":"10.15326\/jcopdf.3.3.2015.0182","article-title":"The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult","volume":"3","author":"Sandhaus","year":"2016","journal-title":"J. COPD Found."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.rmed.2008.10.006","article-title":"Detection of Alpha-1 Antitrypsin Deficiency: A Review","volume":"103","author":"Aboussouan","year":"2009","journal-title":"Respir. Med."},{"key":"ref_34","first-page":"S0300289626000049","article-title":"New Perspectives in the Treatment of Bronchiectasis","volume":"9","author":"Tramontano","year":"2026","journal-title":"Arch. De Bronconeumol."},{"key":"ref_35","unstructured":"Global Initiative for Asthma (GINA) (2026, February 18). Global Strategy for Asthma Management and Prevention, Available online: https:\/\/ginasthma.org\/2025-gina-strategy-report\/."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Habib, N., Pasha, M.A., and Tang, D.D. (2022). Current Understanding of Asthma Pathogenesis and Biomarkers. Cells, 11.","DOI":"10.3390\/cells11172764"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1165\/rcmb.2024-0082WS","article-title":"Asthma Pathogenesis: Phenotypes, Therapies, and Gaps: Summary of the Aspen Lung Conference 2023","volume":"71","author":"Sharma","year":"2024","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1365-2222.2008.02971.x","article-title":"Pathogenesis of Asthma","volume":"38","author":"Holgate","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.03.00112302","article-title":"Effect of Age and Asthma Duration upon Elastase and \u03b11 -Antitrypsin Levels in Adult Asthmatics","volume":"22","author":"Vignola","year":"2003","journal-title":"Eur. Respir. J."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lopez-Campos, J.L., Mu\u00f1oz-S\u00e1nchez, B., Ferrer-Galv\u00e1n, M., and Quintana-Gallego, E. (2025). Alpha-1 Antitrypsin Deficiency and Bronchial Asthma: Current Challenges. Biomolecules, 15.","DOI":"10.3390\/biom15060807"},{"key":"ref_41","first-page":"4","article-title":"Alpha1-Antitrypsin Deficiency and Asthma","volume":"92","author":"Stirpe","year":"2022","journal-title":"Monaldi Arch. Chest. Dis."},{"key":"ref_42","first-page":"352","article-title":"The Prevalence of Alpha-1 Antitrypsin Deficiency Among Patients Found to Have Airflow Obstruction","volume":"9","author":"Rahaghi","year":"2012","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"107222","DOI":"10.1016\/j.rmed.2023.107222","article-title":"Small Airways Disease in Patients with Alpha-1 Antitrypsin Deficiency","volume":"211","author":"Toumpanakis","year":"2023","journal-title":"Respir. Med."},{"key":"ref_44","first-page":"1","article-title":"A-1 Antitrypsin Is a Potential Target of Inflammation and Immunomodulation (Review)","volume":"31","author":"Wang","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/thoraxjnl-2020-215986","article-title":"Neutrophils in Asthma: The Good, the Bad and the Bacteria","volume":"76","author":"Crisford","year":"2021","journal-title":"Thorax"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.it.2017.07.003","article-title":"Neutrophilic Inflammation in Asthma and Association with Disease Severity","volume":"38","author":"Ray","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Henley, K., Tresselt, E., Hook, J.S., Patel, P.A., Gill, M.A., and Moreland, J.G. (2024). Granular Insights: Neutrophil Predominance and Elastase Release in Severe Asthma Exacerbations in a Pediatric Cohort. Cells, 13.","DOI":"10.3390\/cells13060533"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.anai.2013.09.019","article-title":"Distinguishing Alpha1-Antitrypsin Deficiency from Asthma","volume":"111","author":"Siri","year":"2013","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1513\/AnnalsATS.201510-671KV","article-title":"Alpha-1 Antitrypsin Deficiency: Beyond the Protease\/Antiprotease Paradigm","volume":"13","author":"Cosio","year":"2016","journal-title":"Annals ATS"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1513\/AnnalsATS.201611-838OC","article-title":"Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups","volume":"14","author":"Foreman","year":"2017","journal-title":"Annals ATS"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"(2003). American Thoracic Society\/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency. Am. J. Respir. Crit. Care Med., 168, 818\u2013900.","DOI":"10.1164\/rccm.168.7.818"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"423C","DOI":"10.1378\/chest.132.4_MeetingAbstracts.423c","article-title":"Testing for alpha1-antitrypsin deficiency in patients with asthma and\/or chronic obstructive pulmonary disease: A surveillance study","volume":"132","author":"Hogarth","year":"2007","journal-title":"Chest"},{"key":"ref_53","unstructured":"Meseeha, M., Sankari, A., and Attia, M. (2025). Alpha-1 Antitrypsin Deficiency. StatPearls, StatPearls Publishing."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Al\u00ed-Munive, A., Chac\u00f3n, J.L., Prada, L., Proa\u00f1os, N.J., Vargas, L., Diaz-Bossa, C., Giraldo, A., and Pedrozo-Pupo, J. (2025). Prevalence of Genetic Mutations in Alpha-1 Antitrypsin in Patients with Difficult-to-Treat Asthma in Colombia. BMC Pulm. Med., 25.","DOI":"10.1186\/s12890-025-03840-5"},{"key":"ref_55","unstructured":"Global Initiative for Asthma (GINA) (2026, February 18). Difficult-to-Treat & Severe Asthma in Adolescent and Adult Patients: Diagnosis and Management\u2014A GINA Pocket Guide for Health Professionals, Available online: www.ginasthma.org\/reports."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS Guidelines on Definition, Evaluation and Treatment of Severe Asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2222.2012.03983.x","article-title":"Pathogenesis of Severe Asthma","volume":"42","author":"Poon","year":"2012","journal-title":"Clin. Exp. Allergy"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev-pathol-012414-040343","article-title":"Pathobiology of Severe Asthma","volume":"10","author":"Yousem","year":"2015","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaci.2021.12.765","article-title":"Recent Advances in the Immunopathogenesis of Severe Asthma","volume":"149","author":"Ramakrishnan","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1067\/mai.2000.111307","article-title":"Pathophysiology of Severe Asthma","volume":"106","author":"Busse","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Wang, J., and Chen, O. (2021). Identification of Biomarkers and Pathogenesis in Severe Asthma by Coexpression Network Analysis. BMC Med. Genom., 14.","DOI":"10.1186\/s12920-021-00892-4"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/resp.13251","article-title":"Pathophysiology of Severe Asthma: We\u2019ve Only Just Started","volume":"23","author":"King","year":"2018","journal-title":"Respirology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/ACI.0000000000000711","article-title":"Alpha1-Antitrypsin Deficiency and Asthma","volume":"21","author":"Pini","year":"2021","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.rmed.2006.01.009","article-title":"Deficient Alpha-1-Antitrypsin Phenotypes and Persistent Airflow Limitation in Severe Asthma","volume":"100","author":"Rabe","year":"2006","journal-title":"Respir. Med."},{"key":"ref_65","first-page":"19","article-title":"Determination of Alpha-1 Antitrypsin Level in Patients with Severe Asthma","volume":"12","author":"Mousavi","year":"2013","journal-title":"Tanaffos"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jaip.2020.12.061","article-title":"Effect of A1 Antitrypsin Deficiency on Lung Volume Decline in Severe Asthmatic Patients Undergoing Biologic Therapy","volume":"9","author":"Vianello","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5588\/ijtld.23.0493","article-title":"Alpha-1 Deficiency in Severe Asthma Patients","volume":"28","author":"Zappa","year":"2024","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.anai.2024.08.165","article-title":"Alpha-1 antitrypsin deficiency screening in moderate-to-severe asthmatics on or eligible for biologic therapy","volume":"133","author":"Navasero","year":"2024","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/02770900701540028","article-title":"Prevalence of Alpha-1 Antitrypsin Deficiency in Poorly Controlled Asthma\u2014Results from the ALA-ACRC Low-Dose Theophylline Trial","volume":"44","author":"Eden","year":"2007","journal-title":"J. Asthma"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13601-018-0231-x","article-title":"Alpha 1 Antitrypsin Distribution in an Allergic Asthmatic Population Sensitized to House Dust Mites","volume":"8","year":"2018","journal-title":"Clin. Transl. Allergy"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2416870","DOI":"10.1016\/j.pulmoe.2023.05.002","article-title":"Alpha-1 Antitrypsin Deficiency and Pi*S and Pi*Z SERPINA1 Variants Are Associated with Asthma Exacerbations","volume":"31","year":"2025","journal-title":"Pulmonology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.jaip.2025.01.039","article-title":"A1-Antitrypsin Gene Variation Associates With Asthma Exacerbations and Related Health Care Utilization","volume":"13","author":"Ortega","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jaip.2025.03.001","article-title":"Alpha-1 Antitrypsin Deficiency: A Potential Cause of Poor Asthma Control","volume":"13","author":"Akenroye","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4081\/monaldi.2008.380","article-title":"Long-Term Augmentation Therapy with Alpha-1 Antitrypsin in an MZ-AAT Severe Persistent Asthma","volume":"70","author":"Blanco","year":"2016","journal-title":"Monaldi Arch. Chest. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaip.2015.04.005","article-title":"Suspecting and Testing for Alpha-1 Antitrypsin Deficiency\u2014An Allergist\u2019s and\/or Immunologist\u2019s Perspective","volume":"3","author":"Craig","year":"2015","journal-title":"J. Allergy Clin. Immunol. Pract."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/1\/106\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T09:14:01Z","timestamp":1771838041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/1\/106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,22]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["medsci14010106"],"URL":"https:\/\/doi.org\/10.3390\/medsci14010106","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,22]]}}}